CD1d–Natural Killer T cell T-cell receptor complex (CD1d–NKT TCR) (CD1d–NKT TCR)

The CD1d–Natural Killer T (NKT) cell T-cell receptor (TCR) complex is a specialized immune signaling unit composed of the CD1d protein and the T-cell receptor of NKT cells. CD1d is a non-polymorphic, MHC class I-like molecule that functions to present lipid-based antigens, rather than peptides, to the immune system (UniProt P15813). The interaction between the CD1d-lipid complex and the semi-invariant TCR of NKT cells (Vα24-Jα18 in humans) triggers the rapid secretion of a broad range of cytokines, including IFN-gamma and IL-4, which can modulate both innate and adaptive immune branches (PubMed: 24549450). This complex is a major therapeutic target in oncology and infectious diseases, as NKT cell activation can stimulate potent anti-tumor or anti-pathogen responses. Drugs like alpha-galactosylceramide (α-GalCer) and its derivatives act as agonists by binding to the CD1d hydrophobic pocket to facilitate TCR recognition (PubMed: 11544199). However, therapeutic application is challenged by the potential for NKT cell anergy and the risk of systemic cytokine release syndrome (PubMed: 17449723).

Other names

CD1d-NKT TCRCD1d-iNKT TCR complexCD1d-invariant NKT cell receptor complexCD1d-lipid-TCR complexCD1d-NKT receptor

Agonist glycolipids bind to the hydrophobic binding groove of the CD1d molecule; the resulting CD1d-lipid complex is then recognized by the semi-invariant T-cell receptor (TCR) of Natural Killer T (NKT) cells, leading to TCR ligation, intracellular signaling, and the rapid secretion of Th1 and Th2 cytokines (PubMed: 24549450).